NCT02337569View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Zinc Deficiency
Interventions
DRUG

NPC-02

DRUG

Placebos

Trial Locations (1)

Unknown

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT02337569 - A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency | Biotech Hunter | Biotech Hunter